ONCY - neue Einstiegschance mit +300% Potential?
Seite 1 von 4 Neuester Beitrag: 24.04.21 23:41 | ||||
Eröffnet am: | 26.06.15 21:11 | von: biotech1x1 | Anzahl Beiträge: | 76 |
Neuester Beitrag: | 24.04.21 23:41 | von: Anjazzgna | Leser gesamt: | 19.338 |
Forum: | Hot-Stocks | Leser heute: | 12 | |
Bewertet mit: | ||||
Seite: < | 2 | 3 | 4 > |
Nebenbei noch viele Grüsse an die Fans von ADXS, MACK, PLI und Northwest... haben ja einigen (und auch mir) gute Gewinne beschert. Hoffe ihr seid alle noch fit hier. Gruß und schönen Abend an alle
--------------------------------------------------
Share Statistics
Avg Vol (3 month)3: 863,108
Avg Vol (10 day)3: 401,875
Shares Outstanding5: 114.12M
Float: 112.84M§
% Held by Insiders1: N/A
% Held by Institutions1: N/A
Shares Short (as of May 29, 2015)3: 748.00K
Short Ratio (as of May 29, 2015)3: 0.90
Short % of Float (as of May 29, 2015)3: 0.70%
Shares Short (prior month)3: 721.80K
yahoo finance
--------------------------------------------------
Settlement Date Short Interest Avg Daily Share Volume Days To Cover
6/15/2015 804,391§ 545,634 1.474232
5/29/2015 748,003§ 817,541 1.000000
nasdaq
--------------------------------------------------
Hier sind die Leute wohl von Bodenbildung überzeugt bzw. von einer einzigen Richtung: Up. Ja, ich gebe es zu. Bin heute ziemlich stark eingestiegen in USA (für meine Verhältnisse). Ich drücke uns allen die Daumen
Daraus dieser Absatz:
Sell-Side brokerage firms have a price target of $1.125 on shares of Oncolytics Biotech, Inc. (NASDAQ:ONCY). This is based on analysts one year projections on the stock. The most bearish analyst outlook has a price target of $0.75, while the most aggressive firm sees the stock reaching $1.5 within the year.
--------------------
most bearish = $0.75 ? Dann ist ja gut ;-)
Möchte gar nicht wissen was bei most bullish erwartet wird
Oncolytics Biotech Inc. (NASDAQ:ONCY) belongs to Healthcare sector. Its weekly performance is -12.28%. On last trading day company shares ended up $0.50. Oncolytics Biotech Inc. (NASDAQ:ONCY) distance from 50-day simple moving average (SMA50) is -27.23%. Canaccord Genuity reissued their buy rating on shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) in a research report sent to investors on Thursday morning. The firm currently has a $2.50 price target on the stock.
http://www.stocktranscript.com/...stadt-biddle-properties-nyse/29530/
http://money.cnn.com/quote/quote.html?symb=ONCY
http://quotes.wsj.com/ONCY/company-people
Schaut mal unter institutions that own ONCY an, wieviele Aktien zum 31.03.2015 gekauft wurden. Besonders sticht hier der Canada Pension Plan Investment Board raus, überdies noch Morgan Stanley und Nine Chapters - insgesamt 7 Häuser, die im März entweder aufgestockt haben oder neu eingestiegen sind. MfG
Einige User auf den Foren in Übersee gehen von einem Re-Split aus, um einem Delisting zu entgehen. Ich denke - ganz meine eigene Meinung und keine Handelsempfehlung -, dass der Herr Thompson noch vorher eine Kursrakete zünden wird, damit es nicht zu o.g. negativen Konsequenzen kommt. Sollte diese News/Bericht/Mitteilung,etc nicht funktionieren, müsste er dann konsequent einen Re-Split vollziehen.
As you'll see below, once ONCY receives their delisting notice at the end of this 180 days they can request a hearing, submit a plan to reverse split and have an additional 180 days to comply.........This was brought to my attention last week.
3. Delisting Letter: If a company is unable to regain compliance within the grace period (including the additional grace period, if available), NASDAQ will issue a delisting letter. Within four business days of the receipt of the delisting letter, the company must publicly announce the receipt of the letter by filing an 8-K with the SEC.
4. Hearing: Upon receipt of a delisting letter the company will have seven days to submit a written request for a hearing before the NASDAQ Listing Qualifications Panel. The timely submission of this request will stay the delisting process pending the decision of the panel. At a hearing the company will be required to present a plan to regain compliance with the continued listing standards. The plan of compliance should describe the manner in which the company will regain and maintain compliance with the NASDAQ continued listing standards. NASDAQ has stated that the plan should include the implementation of a reverse stock split in the near term – no later than 180 days after receipt of the delisting letter. In determining whether to provide the company with the opportunity to implement its plan of compliance, the panel may consider other factors such as the company’s fundamental financial strengths and weaknesses, the overall market, the company’s historical bid price and impending corporate actions. Fees for a hearing range up to $5,000.
If compliance cannot be demonstrated by October 26, 2015, Nasdaq staff will provide written notification that the Company's securities will be delisted. At that time, the Company may appeal Nasdaq staff's determination to a Hearings Panel.
Read more at http://www.stockhouse.com/news/press-releases/...#KCOhGWr0wFDxGUJk.99
linl
http://www.stockhouse.com/news/press-releases/...liance-with-nasdaq-s